Steven Nelson - UnitedHealth Group Executive Vice President CEO of UnitedHealthcare

UNH Stock  USD 493.64  0.54  0.11%   

CEO

Mr. Steven H. Nelson is Executive Vice President, Chief Executive Officer of UnitedHealthcare of the Company. r. Nelson served as Chief Executive Officer of UnitedHealthcares Medicare Retirement, from March 2014 to August 2017. He served as Chief Executive Officer of UnitedHealthcare Community State from August 2012 to March 2014. From January 2008 to July 2012 he served as President of UnitedHealthcare Community State and then Chief Executive Officer of UnitedHealthcare Employer Individuals West Region business. since 2017.
Age 58
Tenure 7 years
Address UnitedHealth Group Center, Minnetonka, MN, United States, 55343
Phone952 936 1300
Webhttps://www.unitedhealthgroup.com

UnitedHealth Group Management Efficiency

The company has Return on Asset of 0.0779 % which means that on every $100 spent on assets, it made $0.0779 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2499 %, implying that it generated $0.2499 on every 100 dollars invested. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities. The UnitedHealth Group's current Return On Equity is estimated to increase to 0.26, while Return On Capital Employed is projected to decrease to 0.15. As of now, UnitedHealth Group's Total Current Assets are increasing as compared to previous years. The UnitedHealth Group's current Intangible Assets is estimated to increase to about 16 B, while Non Currrent Assets Other are projected to decrease to under 10.9 B.
The company has 67.44 B in debt with debt to equity (D/E) ratio of 0.59, which is OK given its current industry classification. UnitedHealth Group has a current ratio of 0.76, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist UnitedHealth Group until it has trouble settling it off, either with new capital or with free cash flow. So, UnitedHealth Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UnitedHealth Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UnitedHealth to invest in growth at high rates of return. When we think about UnitedHealth Group's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CEO Age

Christopher RowlandMedigus Ltd ADR
56
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. Unitedhealth operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 350000 people. UnitedHealth Group Incorporated (UNH) is traded on New York Stock Exchange in USA. It is located in UnitedHealth Group Center, Minnetonka, MN, United States, 55343 and employs 440,000 people. UnitedHealth Group is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

UnitedHealth Group Leadership Team

Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gail Wilensky, Independent Director
Timothy, Independent Director
Richard Burke, Independent Chairman of the Board
Valerie Rice, Independent Director
Andrew Witty, Group President, Chief Executive Officer, Executive Vice President, Director
Terry Clark, Executive Officer
Sir Witty, CEO Director
Stephen Hemsley, Non-Executive Chairman of the Board
John Rex, Chief Financial Officer, Executive Vice President
Dirk McMahon, President and Chief Operating Officer; Chief Executive Officer of UnitedHealthcare
DEllen Wilson, Executive Vice President - Human Capital
Steven Nelson, Executive Vice President CEO of UnitedHealthcare
Zachary Sopcak, Senior Relations
William McNabb, Independent Director
John Noseworthy, Independent Director
Larry Renfro, Vice Chairman and CEO of Optum
Robert Darretta, Independent Director
Jennifer Smoter, Senior Officer
William Ballard, Independent Director
Glenn Renwick, Independent Director
Rupert Bondy, Ex Officer
Sandeep Dadlani, Executive Officer
Michele Hooper, Lead Independent Director
Timothy Flynn, Independent Director
Thomas Roos, Senior Vice President, Chief Accounting Officer
Rodger Lawson, Independent Director
Frances Jacobs, IR Contact Officer
Matthew Friedrich, Executive Vice President Chief Legal Officer
Kenneth Shine, Independent Director
Edson Bueno, Director
D Wilson, Executive Vice President - Human Capital
F McNabb, Independent Director
Paul Garcia, Independent Director
Marianne Short, Executive Vice President, Chief Legal Officer
David Wichmann, Chief Executive Officer, Director
Patricia Lewis, Chief Human Resource Officer, Executive Vice President
Brian Thompson, Executive UnitedHealthcare
James Barry, Director Pennsylvania

UnitedHealth Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

UnitedHealth Group Investors Sentiment

The influence of UnitedHealth Group's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in UnitedHealth. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to UnitedHealth Group's public news can be used to forecast risks associated with an investment in UnitedHealth. The trend in average sentiment can be used to explain how an investor holding UnitedHealth can time the market purely based on public headlines and social activities around UnitedHealth Group Incorporated. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
UnitedHealth Group's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for UnitedHealth Group's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average UnitedHealth Group's news discussions. The higher the estimated score, the more favorable is the investor's outlook on UnitedHealth Group.

UnitedHealth Group Implied Volatility

    
  24.63  
UnitedHealth Group's implied volatility exposes the market's sentiment of UnitedHealth Group Incorporated stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if UnitedHealth Group's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that UnitedHealth Group stock will not fluctuate a lot when UnitedHealth Group's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards UnitedHealth Group in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, UnitedHealth Group's short interest history, or implied volatility extrapolated from UnitedHealth Group options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for UnitedHealth Stock analysis

When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.16
Dividend Share
7.29
Earnings Share
23.88
Revenue Per Share
400.455
Quarterly Revenue Growth
0.141
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.